SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-042219
Filing Date
2020-09-01
Accepted
2020-09-01 17:16:15
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itos-10q_20200630.htm 10-Q 2656066
2 EX-31.1 itos-ex311_6.htm EX-31.1 18395
3 EX-31.2 itos-ex312_7.htm EX-31.2 18379
4 EX-32.1 itos-ex321_8.htm EX-32.1 11458
  Complete submission text file 0001564590-20-042219.txt   7256572

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itos-20200630.xml EX-101.INS 1276537
6 XBRL TAXONOMY EXTENSION SCHEMA itos-20200630.xsd EX-101.SCH 56096
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itos-20200630_cal.xml EX-101.CAL 39925
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itos-20200630_def.xml EX-101.DEF 220336
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itos-20200630_lab.xml EX-101.LAB 396813
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itos-20200630_pre.xml EX-101.PRE 319590
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 201155088
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences